BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19891889)

  • 1. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
    Nisii C; Castilletti C; Raoul H; Hewson R; Brown D; Gopal R; Eickmann M; Gunther S; Mirazimi A; Koivula T; Feldmann H; Di Caro A; Capobianchi MR; Ippolito G
    PLoS Pathog; 2013 Jan; 9(1):e1003105. PubMed ID: 23349630
    [No Abstract]   [Full Text] [Related]  

  • 6. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
    Nisii C; Vincenti D; Fusco FM; Schmidt-Chanasit J; Carbonnelle C; Raoul H; Eickmann M; Hewson R; Brave A; Nuncio S; Sanchez-Seco MP; Palyi B; Kis Z; Zange S; Nitsche A; Kurth A; Strasser M; Capobianchi MR; Ozin A; Guglielmetti P; Menel-Lemos C; Jacob D; Grunow R; Ippolito G; Di Caro A
    Clin Microbiol Infect; 2017 Feb; 23(2):58-60. PubMed ID: 27404371
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
    Kimman TG; Smit E; Klein MR
    Clin Microbiol Rev; 2008 Jul; 21(3):403-25. PubMed ID: 18625678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY; Xue KN; Jiang JS; Lu XC
    Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosafety news: introducing EBSA--the European Biosafety Association.
    Biotechnol J; 2007 Mar; 2(3):285. PubMed ID: 17354214
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.
    LeDuc JW; Anderson K; Bloom ME; Carrion R; Feldmann H; Fitch JP; Geisbert JB; Geisbert TW; Holbrook MR; Jahrling PB; Ksiazek TG
    Emerg Infect Dis; 2009 Jul; 15(7):e1. PubMed ID: 19624910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosafety: guidelines for working with pathogenic and infectious microorganisms.
    Coico R; Lunn G
    Curr Protoc Immunol; 2005 Nov; Appendix 1():A.1V.1-A.1V.8. PubMed ID: 18432937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of biosafety measures in clinical laboratories of Al-Madinah city, Saudi Arabia.
    Khabour OF; Al Ali KH; Aljuhani JN; Alrashedi MA; Alharbe FH; Sanyowr A
    J Infect Dev Ctries; 2018 Sep; 12(9):755-761. PubMed ID: 31999634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety lab passes disaster test.
    Dalton R
    Nature; 2008 Oct; 455(7216):1012. PubMed ID: 18948912
    [No Abstract]   [Full Text] [Related]  

  • 14. Arthropod containment guidelines. A project of the American Committee of Medical Entomology and American Society of Tropical Medicine and Hygiene.
    ;
    Vector Borne Zoonotic Dis; 2003; 3(2):61-98. PubMed ID: 12908960
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosafety: guidelines for working with pathogenic and infectious microorganisms.
    Burnett LC; Lunn G; Coico R
    Curr Protoc Microbiol; 2009 May; Chapter 1(1):Unit 1A.1. PubMed ID: 19412909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosafety breaches. Accidents spur a closer look at risks at biodefense labs.
    Kaiser J
    Science; 2007 Sep; 317(5846):1852-4. PubMed ID: 17901309
    [No Abstract]   [Full Text] [Related]  

  • 18. Containing risk.
    Nature; 2009 Nov; 462(7270):137. PubMed ID: 19907446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basics of animal biosafety and biocontainment training.
    Pritt S; Hankenson FC; Wagner T; Tate M
    Lab Anim (NY); 2007 Jun; 36(6):31-8. PubMed ID: 17519943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.